DRDO Successfully Conducts High-Altitude Trials
DEFENSE

DRDO Successfully Conducts High-Altitude Trials

The Defence Bio-Engineering & Electro Medical Laboratory (DEBEL), a Bengaluru-based DRDO lab, has successfully completed high-altitude trials of the On-Board Oxygen Generating System (OBOGS)-based Integrated Life Support System (ILSS) for the LCA Tejas aircraft. The milestone trials were conducted on March 4, 2025, demonstrating India’s advancements in self-reliant aerospace technology.

Revolutionary Life Support System for Fighter Pilots The OBOGS-based ILSS is a state-of-the-art oxygen generation and regulation system, eliminating the dependence on traditional liquid oxygen cylinders. This ensures a continuous and real-time supply of breathable oxygen, enhancing pilot endurance, safety, and operational efficiency in extreme combat conditions.

The ILSS underwent rigorous testing on Hindustan Aeronautics Limited (HAL)’s LCA-Prototype Vehicle-3, in collaboration with the Aeronautical Development Agency (ADA). It successfully functioned in diverse flight conditions, including: ? Altitudes up to 50,000 feet Above Mean Sea Level ? High-G maneuvers ? Oxygen demand breathing tests ? Full functionality validation of Anti-G Valve & Breathing Oxygen System (BOS)

The Centre for Military Airworthiness & Certification (CEMILAC) granted clearance for the flight tests, ensuring compliance with stringent aeromedical and operational standards.

Indigenous Manufacturing & Strategic Collaboration The ILSS integrates 10 Line Replaceable Units (LRUs), including: ???? Low-Pressure Breathing Regulator ???? Emergency Oxygen System ???? Oxygen Sensor ???? Anti-G Valve

With 90% indigenous content, the system represents a major step in India’s Atmanirbhar Bharat initiative. Manufactured by L&T as a Development cum Production Partner, it exemplifies successful collaboration between DRDO, HAL, ADA, CEMILAC, the National Flight Test Center, Directorate General of Aeronautical Quality Assurance (DGAQA), and the Indian Air Force (IAF).

Potential Deployment Across Fighter Fleets Beyond its integration with LCA Tejas, the ILSS has the capability to be adapted for other fighter aircraft, including the MiG-29K. This development paves the way for enhanced pilot safety and efficiency across India's aerial combat platforms.

Leaders Applaud India’s Aerospace Advancements Raksha Mantri Shri Rajnath Singh lauded DRDO, the IAF, and industry partners, stating that this breakthrough strengthens India’s defence capabilities and aligns with the vision of ‘Viksit Bharat 2047’.

Dr. Samir V Kamat, Secretary, Department of Defence R&D and Chairman DRDO, also commended the successful trials, emphasising India’s commitment to cutting-edge defence technology and self-reliance in aerospace innovation. With this landmark achievement, India cements its position among global leaders in indigenous military aviation technology, ensuring superior pilot survivability and enhanced operational effectiveness in high-altitude combat missions.

The Defence Bio-Engineering & Electro Medical Laboratory (DEBEL), a Bengaluru-based DRDO lab, has successfully completed high-altitude trials of the On-Board Oxygen Generating System (OBOGS)-based Integrated Life Support System (ILSS) for the LCA Tejas aircraft. The milestone trials were conducted on March 4, 2025, demonstrating India’s advancements in self-reliant aerospace technology. Revolutionary Life Support System for Fighter Pilots The OBOGS-based ILSS is a state-of-the-art oxygen generation and regulation system, eliminating the dependence on traditional liquid oxygen cylinders. This ensures a continuous and real-time supply of breathable oxygen, enhancing pilot endurance, safety, and operational efficiency in extreme combat conditions. The ILSS underwent rigorous testing on Hindustan Aeronautics Limited (HAL)’s LCA-Prototype Vehicle-3, in collaboration with the Aeronautical Development Agency (ADA). It successfully functioned in diverse flight conditions, including: ? Altitudes up to 50,000 feet Above Mean Sea Level ? High-G maneuvers ? Oxygen demand breathing tests ? Full functionality validation of Anti-G Valve & Breathing Oxygen System (BOS) The Centre for Military Airworthiness & Certification (CEMILAC) granted clearance for the flight tests, ensuring compliance with stringent aeromedical and operational standards. Indigenous Manufacturing & Strategic Collaboration The ILSS integrates 10 Line Replaceable Units (LRUs), including: ???? Low-Pressure Breathing Regulator ???? Emergency Oxygen System ???? Oxygen Sensor ???? Anti-G Valve With 90% indigenous content, the system represents a major step in India’s Atmanirbhar Bharat initiative. Manufactured by L&T as a Development cum Production Partner, it exemplifies successful collaboration between DRDO, HAL, ADA, CEMILAC, the National Flight Test Center, Directorate General of Aeronautical Quality Assurance (DGAQA), and the Indian Air Force (IAF). Potential Deployment Across Fighter Fleets Beyond its integration with LCA Tejas, the ILSS has the capability to be adapted for other fighter aircraft, including the MiG-29K. This development paves the way for enhanced pilot safety and efficiency across India's aerial combat platforms. Leaders Applaud India’s Aerospace Advancements Raksha Mantri Shri Rajnath Singh lauded DRDO, the IAF, and industry partners, stating that this breakthrough strengthens India’s defence capabilities and aligns with the vision of ‘Viksit Bharat 2047’. Dr. Samir V Kamat, Secretary, Department of Defence R&D and Chairman DRDO, also commended the successful trials, emphasising India’s commitment to cutting-edge defence technology and self-reliance in aerospace innovation. With this landmark achievement, India cements its position among global leaders in indigenous military aviation technology, ensuring superior pilot survivability and enhanced operational effectiveness in high-altitude combat missions.

Related Stories

Next Story
Infrastructure Energy

Asian Energy Services Q1 FY27 PAT Rises 129 Per Cent

Asian Energy Services Limited reported a 129 per cent year-on-year rise in net profit to Rs 128 million for Q1 FY27, compared with the corresponding quarter last year.Revenue increased 135 per cent year-on-year to Rs 2.71 billion, supported by continued momentum across its services business, disciplined execution and contributions from domestic and international operations. EBITDA grew 81 per cent year-on-year during the quarter.As of June 30, 2026, the company’s standalone order book stood at Rs 17.54 billion, with around 60 per cent coming from oil and gas services and 40 per cent from min..

Next Story
Infrastructure Urban

BioBTX to Build First Commercial-Scale Circular Chemicals Plant

Dutch circular chemistry technology developer BioBTX is building what it says will be the world’s first commercial-scale plant to convert mixed plastic waste into high-quality aromatic chemicals using its proprietary Integrated Catalytic Cracking Process (ICCP) technology.The facility will be built at Chemical Park Delfzijl on the northern coast of the Netherlands and is expected to create 35 jobs. Covestro, which has been a shareholder and strategic partner of BioBTX since 2024, holds a mid-single-digit million-euro investment in the company.BioBTX’s ICCP technology uses catalytic pyrolys..

Next Story
Real Estate

Awfis Q1 FY27 PAT Jumps 140% as Revenue Rises 27%

Awfis Space Solutions reported a 140 per cent year-on-year rise in consolidated profit after tax (PAT) to Rs 240 million for Q1 FY27, compared with Rs 100 million in the corresponding quarter last year.Revenue from operations increased 27 per cent to Rs 4.25 billion from Rs 3.35 billion, while EBITDA rose 28 per cent to Rs 1.62 billion. EBITDA margin improved to 38.2 per cent from 37.8 per cent. Profit before tax increased 135 per cent to Rs 240 million.The company's co-working business recorded 27 per cent year-on-year growth, supported by demand from enterprises, Global Capability Centres (G..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement